| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108733f491541573d65101158ebb7fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5523a6596f3f408303a7c44014191d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1d4738041c67a2c7e2739e1fedd93b9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| filingDate |
2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e192df60ec6e8c08aa5aa4243272d56 |
| publicationDate |
2009-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009122351-A2 |
| titleOfInvention |
Anti-parkinsonian compounds mppe |
| abstract |
The present application describes a composition comprising a neuroprotective effective amount of N-methyl-N-propynyl-2-phenylethylamine (MPPE). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111317813-A |
| priorityDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |